Global Arthritis Drug Market Research Report 2023

Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.

The global Arthritis Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

Growing burden of incidence of osteoarthritis, psoriatic arthritis and rheumatoid arthritis patients are major factors driving the growth of global arthritis drugs market. According to CDC estimation from 2010-2012, about 52.5 million US adults had some form of arthritis conditions among them persons with age 65 or older reported higher prevalence of arthritis conditions than the other ages due to “wear and tear” on the joints. However, due to lack of proper medication to cure arthritis and higher cost of the medications are hindering the growth of this market over the forecast period.

This report aims to provide a comprehensive presentation of the global market for Arthritis Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arthritis Drug.

The Arthritis Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Arthritis Drug market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Arthritis Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Arthritis Drug

1.2 Arthritis Drug Segment by Type

1.2.1 Global Arthritis Drug Market Value Comparison by Type (2023-2029)

1.2.2 Synthetic DMARDs

1.2.3 Biological DMARDs

1.2.4 NSAIDs

1.2.5 Corticosteroids

1.2.6 Analgesics

1.3 Arthritis Drug Segment by Application

1.3.1 Global Arthritis Drug Market Value by Application: (2023-2029)

1.3.2 Retail Pharmacies

1.3.3 Hospital Pharmacies

1.3.4 Drug Stores

1.3.5 E-Commerce

1.4 Global Arthritis Drug Market Size Estimates and Forecasts

1.4.1 Global Arthritis Drug Revenue 2018-2029

1.4.2 Global Arthritis Drug Sales 2018-2029

1.4.3 Global Arthritis Drug Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Arthritis Drug Sales Market Share by Manufacturers (2018-2023)

2.2 Global Arthritis Drug Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Arthritis Drug Average Price by Manufacturers (2018-2023)

2.4 Global Arthritis Drug Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Arthritis Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Arthritis Drug, Product Type & Application

2.7 Arthritis Drug Market Competitive Situation and Trends

2.7.1 Arthritis Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Arthritis Drug Players Market Share by Revenue

2.7.3 Global Arthritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Arthritis Drug Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Arthritis Drug Global Arthritis Drug Sales by Region: 2018-2029

3.2.1 Global Arthritis Drug Sales by Region: 2018-2023

3.2.2 Global Arthritis Drug Sales by Region: 2024-2029

3.3 Global Arthritis Drug Global Arthritis Drug Revenue by Region: 2018-2029

3.3.1 Global Arthritis Drug Revenue by Region: 2018-2023

3.3.2 Global Arthritis Drug Revenue by Region: 2024-2029

3.4 North America Arthritis Drug Market Facts & Figures by Country

3.4.1 North America Arthritis Drug Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Arthritis Drug Sales by Country (2018-2029)

3.4.3 North America Arthritis Drug Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Arthritis Drug Market Facts & Figures by Country

3.5.1 Europe Arthritis Drug Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Arthritis Drug Sales by Country (2018-2029)

3.5.3 Europe Arthritis Drug Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Arthritis Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Arthritis Drug Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Arthritis Drug Sales by Country (2018-2029)

3.6.3 Asia Pacific Arthritis Drug Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Arthritis Drug Market Facts & Figures by Country

3.7.1 Latin America Arthritis Drug Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Arthritis Drug Sales by Country (2018-2029)

3.7.3 Latin America Arthritis Drug Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Arthritis Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Arthritis Drug Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Arthritis Drug Sales by Country (2018-2029)

3.8.3 Middle East and Africa Arthritis Drug Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Arthritis Drug Sales by Type (2018-2029)

4.1.1 Global Arthritis Drug Sales by Type (2018-2023)

4.1.2 Global Arthritis Drug Sales by Type (2024-2029)

4.1.3 Global Arthritis Drug Sales Market Share by Type (2018-2029)

4.2 Global Arthritis Drug Revenue by Type (2018-2029)

4.2.1 Global Arthritis Drug Revenue by Type (2018-2023)

4.2.2 Global Arthritis Drug Revenue by Type (2024-2029)

4.2.3 Global Arthritis Drug Revenue Market Share by Type (2018-2029)

4.3 Global Arthritis Drug Price by Type (2018-2029)

5.1 Global Arthritis Drug Sales by Application (2018-2029)

5.1.1 Global Arthritis Drug Sales by Application (2018-2023)

5.1.2 Global Arthritis Drug Sales by Application (2024-2029)

5.1.3 Global Arthritis Drug Sales Market Share by Application (2018-2029)

5.2 Global Arthritis Drug Revenue by Application (2018-2029)

5.2.1 Global Arthritis Drug Revenue by Application (2018-2023)

5.2.2 Global Arthritis Drug Revenue by Application (2024-2029)

5.2.3 Global Arthritis Drug Revenue Market Share by Application (2018-2029)

5.3 Global Arthritis Drug Price by Application (2018-2029)

6.1 Novartis

6.1.1 Novartis Corporation Information

6.1.2 Novartis Description and Business Overview

6.1.3 Novartis Arthritis Drug Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Novartis Arthritis Drug Product Portfolio

6.1.5 Novartis Recent Developments/Updates

6.2 Eli Lilly

6.2.1 Eli Lilly Corporation Information

6.2.2 Eli Lilly Description and Business Overview

6.2.3 Eli Lilly Arthritis Drug Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Eli Lilly Arthritis Drug Product Portfolio

6.2.5 Eli Lilly Recent Developments/Updates

6.3 Celltrion

6.3.1 Celltrion Corporation Information

6.3.2 Celltrion Description and Business Overview

6.3.3 Celltrion Arthritis Drug Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Celltrion Arthritis Drug Product Portfolio

6.3.5 Celltrion Recent Developments/Updates

6.4 F. Hoffmann-La Roche

6.4.1 F. Hoffmann-La Roche Corporation Information

6.4.2 F. Hoffmann-La Roche Description and Business Overview

6.4.3 F. Hoffmann-La Roche Arthritis Drug Sales, Revenue and Gross Margin (2018-2023)

6.4.4 F. Hoffmann-La Roche Arthritis Drug Product Portfolio

6.4.5 F. Hoffmann-La Roche Recent Developments/Updates

6.5 Pfizer

6.5.1 Pfizer Corporation Information

6.5.2 Pfizer Description and Business Overview

6.5.3 Pfizer Arthritis Drug Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Pfizer Arthritis Drug Product Portfolio

6.5.5 Pfizer Recent Developments/Updates

6.6 Johnson & Johnson

6.6.1 Johnson & Johnson Corporation Information

6.6.2 Johnson & Johnson Description and Business Overview

6.6.3 Johnson & Johnson Arthritis Drug Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Johnson & Johnson Arthritis Drug Product Portfolio

6.6.5 Johnson & Johnson Recent Developments/Updates

6.7 GSK

6.6.1 GSK Corporation Information

6.6.2 GSK Description and Business Overview

6.6.3 GSK Arthritis Drug Sales, Revenue and Gross Margin (2018-2023)

6.4.4 GSK Arthritis Drug Product Portfolio

6.7.5 GSK Recent Developments/Updates

7.1 Arthritis Drug Industry Chain Analysis

7.2 Arthritis Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Arthritis Drug Production Mode & Process

7.4 Arthritis Drug Sales and Marketing

7.4.1 Arthritis Drug Sales Channels

7.4.2 Arthritis Drug Distributors

7.5 Arthritis Drug Customers

8.1 Arthritis Drug Industry Trends

8.2 Arthritis Drug Market Drivers

8.3 Arthritis Drug Market Challenges

8.4 Arthritis Drug Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Arthritis Drug Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Arthritis Drug Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Arthritis Drug Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Arthritis Drug Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Arthritis Drug Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Arthritis Drug Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Arthritis Drug Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Arthritis Drug Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Arthritis Drug, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Arthritis Drug, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Arthritis Drug, Product Type & Application

    Table 12. Global Key Manufacturers of Arthritis Drug, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Arthritis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arthritis Drug as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Arthritis Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Arthritis Drug Sales by Region (2018-2023) & (K Units)

    Table 18. Global Arthritis Drug Sales Market Share by Region (2018-2023)

    Table 19. Global Arthritis Drug Sales by Region (2024-2029) & (K Units)

    Table 20. Global Arthritis Drug Sales Market Share by Region (2024-2029)

    Table 21. Global Arthritis Drug Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Arthritis Drug Revenue Market Share by Region (2018-2023)

    Table 23. Global Arthritis Drug Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Arthritis Drug Revenue Market Share by Region (2024-2029)

    Table 25. North America Arthritis Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Arthritis Drug Sales by Country (2018-2023) & (K Units)

    Table 27. North America Arthritis Drug Sales by Country (2024-2029) & (K Units)

    Table 28. North America Arthritis Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Arthritis Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Arthritis Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Arthritis Drug Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Arthritis Drug Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Arthritis Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Arthritis Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Arthritis Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Arthritis Drug Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Arthritis Drug Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Arthritis Drug Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Arthritis Drug Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Arthritis Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Arthritis Drug Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Arthritis Drug Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Arthritis Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Arthritis Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Arthritis Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Arthritis Drug Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Arthritis Drug Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Arthritis Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Arthritis Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Arthritis Drug Sales (K Units) by Type (2018-2023)

    Table 51. Global Arthritis Drug Sales (K Units) by Type (2024-2029)

    Table 52. Global Arthritis Drug Sales Market Share by Type (2018-2023)

    Table 53. Global Arthritis Drug Sales Market Share by Type (2024-2029)

    Table 54. Global Arthritis Drug Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Arthritis Drug Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Arthritis Drug Revenue Market Share by Type (2018-2023)

    Table 57. Global Arthritis Drug Revenue Market Share by Type (2024-2029)

    Table 58. Global Arthritis Drug Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Arthritis Drug Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Arthritis Drug Sales (K Units) by Application (2018-2023)

    Table 61. Global Arthritis Drug Sales (K Units) by Application (2024-2029)

    Table 62. Global Arthritis Drug Sales Market Share by Application (2018-2023)

    Table 63. Global Arthritis Drug Sales Market Share by Application (2024-2029)

    Table 64. Global Arthritis Drug Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Arthritis Drug Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Arthritis Drug Revenue Market Share by Application (2018-2023)

    Table 67. Global Arthritis Drug Revenue Market Share by Application (2024-2029)

    Table 68. Global Arthritis Drug Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Arthritis Drug Price (USD/Unit) by Application (2024-2029)

    Table 70. Novartis Corporation Information

    Table 71. Novartis Description and Business Overview

    Table 72. Novartis Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. Novartis Arthritis Drug Product

    Table 74. Novartis Recent Developments/Updates

    Table 75. Eli Lilly Corporation Information

    Table 76. Eli Lilly Description and Business Overview

    Table 77. Eli Lilly Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. Eli Lilly Arthritis Drug Product

    Table 79. Eli Lilly Recent Developments/Updates

    Table 80. Celltrion Corporation Information

    Table 81. Celltrion Description and Business Overview

    Table 82. Celltrion Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. Celltrion Arthritis Drug Product

    Table 84. Celltrion Recent Developments/Updates

    Table 85. F. Hoffmann-La Roche Corporation Information

    Table 86. F. Hoffmann-La Roche Description and Business Overview

    Table 87. F. Hoffmann-La Roche Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. F. Hoffmann-La Roche Arthritis Drug Product

    Table 89. F. Hoffmann-La Roche Recent Developments/Updates

    Table 90. Pfizer Corporation Information

    Table 91. Pfizer Description and Business Overview

    Table 92. Pfizer Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. Pfizer Arthritis Drug Product

    Table 94. Pfizer Recent Developments/Updates

    Table 95. Johnson & Johnson Corporation Information

    Table 96. Johnson & Johnson Description and Business Overview

    Table 97. Johnson & Johnson Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Johnson & Johnson Arthritis Drug Product

    Table 99. Johnson & Johnson Recent Developments/Updates

    Table 100. GSK Corporation Information

    Table 101. GSK Description and Business Overview

    Table 102. GSK Arthritis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. GSK Arthritis Drug Product

    Table 104. GSK Recent Developments/Updates

    Table 105. Key Raw Materials Lists

    Table 106. Raw Materials Key Suppliers Lists

    Table 107. Arthritis Drug Distributors List

    Table 108. Arthritis Drug Customers List

    Table 109. Arthritis Drug Market Trends

    Table 110. Arthritis Drug Market Drivers

    Table 111. Arthritis Drug Market Challenges

    Table 112. Arthritis Drug Market Restraints

    Table 113. Research Programs/Design for This Report

    Table 114. Key Data Information from Secondary Sources

    Table 115. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Arthritis Drug

    Figure 2. Global Arthritis Drug Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Arthritis Drug Market Share by Type in 2022 & 2029

    Figure 4. Synthetic DMARDs Product Picture

    Figure 5. Biological DMARDs Product Picture

    Figure 6. NSAIDs Product Picture

    Figure 7. Corticosteroids Product Picture

    Figure 8. Analgesics Product Picture

    Figure 9. Global Arthritis Drug Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 10. Global Arthritis Drug Market Share by Application in 2022 & 2029

    Figure 11. Retail Pharmacies

    Figure 12. Hospital Pharmacies

    Figure 13. Drug Stores

    Figure 14. E-Commerce

    Figure 15. Global Arthritis Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Arthritis Drug Market Size (2018-2029) & (US$ Million)

    Figure 17. Global Arthritis Drug Sales (2018-2029) & (K Units)

    Figure 18. Global Arthritis Drug Average Price (USD/Unit) & (2018-2029)

    Figure 19. Arthritis Drug Report Years Considered

    Figure 20. Arthritis Drug Sales Share by Manufacturers in 2022

    Figure 21. Global Arthritis Drug Revenue Share by Manufacturers in 2022

    Figure 22. The Global 5 and 10 Largest Arthritis Drug Players: Market Share by Revenue in 2022

    Figure 23. Arthritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 24. Global Arthritis Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 25. North America Arthritis Drug Sales Market Share by Country (2018-2029)

    Figure 26. North America Arthritis Drug Revenue Market Share by Country (2018-2029)

    Figure 27. U.S. Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. Canada Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. Europe Arthritis Drug Sales Market Share by Country (2018-2029)

    Figure 30. Europe Arthritis Drug Revenue Market Share by Country (2018-2029)

    Figure 31. Germany Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. France Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. U.K. Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Italy Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Russia Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Asia Pacific Arthritis Drug Sales Market Share by Region (2018-2029)

    Figure 37. Asia Pacific Arthritis Drug Revenue Market Share by Region (2018-2029)

    Figure 38. China Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Japan Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. South Korea Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. India Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Australia Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Taiwan Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Indonesia Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Thailand Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Malaysia Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Philippines Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Latin America Arthritis Drug Sales Market Share by Country (2018-2029)

    Figure 49. Latin America Arthritis Drug Revenue Market Share by Country (2018-2029)

    Figure 50. Mexico Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Brazil Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Argentina Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Middle East & Africa Arthritis Drug Sales Market Share by Country (2018-2029)

    Figure 54. Middle East & Africa Arthritis Drug Revenue Market Share by Country (2018-2029)

    Figure 55. Turkey Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 56. Saudi Arabia Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 57. U.A.E Arthritis Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 58. Global Sales Market Share of Arthritis Drug by Type (2018-2029)

    Figure 59. Global Revenue Market Share of Arthritis Drug by Type (2018-2029)

    Figure 60. Global Arthritis Drug Price (USD/Unit) by Type (2018-2029)

    Figure 61. Global Sales Market Share of Arthritis Drug by Application (2018-2029)

    Figure 62. Global Revenue Market Share of Arthritis Drug by Application (2018-2029)

    Figure 63. Global Arthritis Drug Price (USD/Unit) by Application (2018-2029)

    Figure 64. Arthritis Drug Value Chain

    Figure 65. Arthritis Drug Production Process

    Figure 66. Channels of Distribution (Direct Vs Distribution)

    Figure 67. Distributors Profiles

    Figure 68. Bottom-up and Top-down Approaches for This Report

    Figure 69. Data Triangulation

    Figure 70. Key Executives Interviewed